Effects of environmental cadmium and lead exposure on adults neighboring a discharge: Evidences of adverse health effects

2015 ◽  
Vol 206 ◽  
pp. 247-255 ◽  
Author(s):  
Mathilde Cabral ◽  
Aminata Toure ◽  
Guillaume Garçon ◽  
Cheikh Diop ◽  
Saâd Bouhsina ◽  
...  
2010 ◽  
Vol 26 (8) ◽  
pp. 497-504 ◽  
Author(s):  
Dilshad Ahmed Khan ◽  
Shazia Qayyum ◽  
Shahid Saleem ◽  
Wafa Munir Ansari ◽  
Farooq Ahmad Khan

2014 ◽  
Vol 2014 ◽  
pp. 1-9 ◽  
Author(s):  
Aaron James Specht ◽  
Marc Weisskopf ◽  
Linda Huiling Nie

Lead is a ubiquitous toxicant. Bone lead has been established as an important biomarker for cumulative lead exposures and has been correlated with adverse health effects on many systems in the body. K-shell X-ray fluorescence (KXRF) is the standard method for measuring bone lead, but this approach has many difficulties that have limited the widespread use of this exposure assessment method. With recent advancements in X-ray fluorescence (XRF) technology, we have developed a portable system that can quantify lead in bone in vivo within 3 minutes. Our study investigated improvements to the system, four calibration methods, and system validation for in vivo measurements. Our main results show that the detection limit of the system is 2.9 ppm with 2 mm soft tissue thickness, the best calibration method for in vivo measurement is background subtraction, and there is strong correlation between KXRF and portable LXRF bone lead results. Our results indicate that the technology is ready to be used in large human population studies to investigate adverse health effects of lead exposure. The portability of the system and fast measurement time should allow for this technology to greatly advance the research on lead exposure and public/environmental health.


2009 ◽  
Vol 407 (23) ◽  
pp. 5986-5992 ◽  
Author(s):  
Q. Wang ◽  
H.H. Zhao ◽  
J.W. Chen ◽  
K.D. Gu ◽  
Y.Z. Zhang ◽  
...  

BMJ Open ◽  
2021 ◽  
Vol 11 (5) ◽  
pp. e044833
Author(s):  
Gabriel Silver ◽  
Yordanka Krastev ◽  
Miriam K Forbes ◽  
Brenton Hamdorf ◽  
Barry Lewis ◽  
...  

IntroductionPerfluoroalkyl and polyfluoroalkyl substances (PFAS) are a diverse group of compounds that have been used in hundreds of industrial applications and consumer products including aqueous film-forming foam (AFFF) for many years. Multiple national and international health and environmental agencies have accepted that PFAS exposures are associated with numerous adverse health effects. Australian firefighters have been shown to have elevated levels of PFAS in their blood, specifically perfluorooctane sulfonic acid (PFOS) and perfluorohexane sulfonic acid (PFHxS), due to the historical use of AFFF. While PFAS concentrations decline over time once the source of exposure has been removed, their potential adverse health effects are such that it would be prudent to develop an intervention to lower levels at a faster rate than occurs via natural elimination rates.Methods and analysisThis is a randomised controlled trial of current and former Australian firefighters in the Metropolitan Fire Brigade/Fire Rescue Victoria, and contractors, with previous occupational exposure to PFAS and baseline elevated PFOS levels. The study is investigating whether whole blood donation every 12 weeks or plasma donation every 6 weeks will significantly reduce PFAS levels, compared with a control group. We have used covariate-adaptive randomisation to balance participants’ sex and blood PFAS levels between the three groups and would consider a 25% reduction in serum PFOS and PFHxS levels to be potentially clinically significant after 12 months of whole blood or plasma donation. A secondary analysis of health biomarkers is being made of changes between screening and week 52 in all three groups.Ethics and disseminationThis trial has been approved by Macquarie University Human Research Ethics Committee (reference number: 3855), final protocol V.2 dated 12 June 2019. Study results will be disseminated via peer-reviewed publications and presentations at conferences.Trial registration numberAustralian New Zealand Clinical Trials Registry (ACTRN12619000204145).


2021 ◽  
pp. 105971232198909
Author(s):  
Harry Heft

It is usually a mark of good design when technologies and tools that mediate goal-directed action are such that the user’s attentional focus is maintained on the intended ends of action rather than on the technologies and tools themselves. When the mediators become the focus, the continuity of goal-directed action is disrupted, and the flow of action can be re-directed. What then is the purpose of the projects designed by the RAAAF studio, as described by Rietveld, which seem to be intended to do both? Disruption of the continuity of goal-directed perception-action may prompt reflection about the circumstances at work, and in so doing provoke a transformation in habitual patterns of action and of thought. The project “The End of Sitting” is intended to remediate the adverse health effects of standard chair-dominated offices through an unconventional office landscape that prompts intermittent postural readjustments, boosting the levels of activity common in such settings. The project “Bunker 599” demonstrates that seemingly unremarkable features of the landscape can sometimes conceal aspects of culture’s history, and that design can function to draw attention to a hidden and even vanishing history. Design can enrich an individual’s sense of place in a stream of cultural history.


2019 ◽  
Vol 20 (19) ◽  
pp. 4901 ◽  
Author(s):  
Leonardo M. R. Ferreira ◽  
Teresa Cunha-Oliveira ◽  
Margarida C. Sobral ◽  
Patrícia L. Abreu ◽  
Maria Carmen Alpoim ◽  
...  

Worldwide, several million workers are employed in the various chromium (Cr) industries. These workers may suffer from a variety of adverse health effects produced by dusts, mists and fumes containing Cr in the hexavalent oxidation state, Cr(VI). Of major importance, occupational exposure to Cr(VI) compounds has been firmly associated with the development of lung cancer. Counterintuitively, Cr(VI) is mostly unreactive towards most biomolecules, including nucleic acids. However, its intracellular reduction produces several species that react extensively with biomolecules. The diversity and chemical versatility of these species add great complexity to the study of the molecular mechanisms underlying Cr(VI) toxicity and carcinogenicity. As a consequence, these mechanisms are still poorly understood, in spite of intensive research efforts. Here, we discuss the impact of Cr(VI) on the stress response—an intricate cellular system against proteotoxic stress which is increasingly viewed as playing a critical role in carcinogenesis. This discussion is preceded by information regarding applications, chemical properties and adverse health effects of Cr(VI). A summary of our current understanding of cancer initiation, promotion and progression is also provided, followed by a brief description of the stress response and its links to cancer and by an overview of potential molecular mechanisms of Cr(VI) carcinogenicity.


Sign in / Sign up

Export Citation Format

Share Document